[Arginine glucose-1-phosphate in liver lesions due to antiepileptic drugs. Its effectiveness on the frequency of epileptic crises. Pathogenesis of the epileptic attack].
D000927:Anticonvulsants / Q000009:adverse effects*; D001120:Arginine / Q000627:therapeutic use*; D050260:Carbohydrate Metabolism; D056486:Chemical and Drug Induced Liver Injury; D004827:Epilepsy / Q000188:drug therapy* / Q000378:metabolism; D005947:Glucose / Q000627:therapeutic use*; D005958:Glucosephosphates / Q000627:therapeutic use; D006600:Hexosephosphates / Q000627:therapeutic use*; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*
D000927:Anticonvulsants; D005958:Glucosephosphates; D006600:Hexosephosphates; D001120:Arginine; D005947:Glucose
Il glucosio-1-fosfato di arginina nel danno epatico da farmaci antiepilettici. Sua efficacia anche sulla frequenza delle crisi epilettiche. Considerazioni sulla patogenesi dell'accesso epilettico.